Posted by Michael Wonder on 17 Jan 2025
Seladelpar approved to treat adult patients in the UK with liver illness
16 January 2025 - As with any medicine, the MHRA will keep the safety and effectiveness of seladelpar under close review.
The MHRA has today approved the medicine seladelpar (Livdelzi) in adults for the treatment of a liver illness called primary biliary cholangitis, including pruritus.
